5Chen JJ,Swope DM.Clinical pharmacology of rasagiline:a novel,second-generation propargylamine for the treatment of Parkinson disease[J].J Clin Pharmacol,2005,45(8):878-894.
6Youdim MB,Maruyama W,Naoi M.Neuropharmacological,neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug,rasagiline[J].Drugs Today,2005,41(6):369-391.
7Gu FG,Hao D,Meng GDL,et al.Preparation of bisoprolol fumarate nasal spray and its nasal delivery in rats[J].Pak J Pharm Sci,2015,28(6):2173-2178.
8Ravi PR,Aditya N,Cherian L,et al.LC method for determination of rasagiline mesylate in different plasma matrices and its application to oral pharmacokinetic study in rabbits[J].J Chromatogr Sci,2013,51(1):1-7.
9Ravi PR,Aditya N,Patil S,et al.Nasal in-situ gels for delivery of rasagiline mesylate:improvement in bioavailability and brain localization[J].Drug Deliv,2015,22(7):903-910.
